Tempest Therapeutics, Inc. Common Stock

TPSTNASDAQ • USD
0.32 USD
↘ 0.01 (3.76%)🟢PRE MARKET (AS OF 07:56 AM EST)
🟢Market: OPEN

Shares of Tempest Therapeutics, Inc. Common Stock (TPST) are trading at $0.32. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (2174.0%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 18, 2026.

Open?$0.31
High?$0.33
Low?$0.31
Prev. Close?$0.33
Volume?9.0K
Avg. Volume?201.9K
VWAP?$0.32
Rel. Volume?0.04x
Bid / Ask
Bid?$0.26 × 100
Ask?$0.36 × 100
Spread?$0.10
Midpoint?$0.31
Valuation & Ratios
Market Cap?6.2M
Shares Out?20.0M
Float?7.2M
Float %?45.1%
P/E Ratio?N/A
P/B Ratio?-3.39
EPS?-$1.99
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.
Employees
4
Market Cap
6.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-06-28
Address
2000 SIERRA POINT PARKWAY
BRISBANE, CA 94005
Phone: 415-798-8589
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
85
Piotroski F-Score?0/9Weak
Altman Z-Score?-59.66Distress
Confidence?43%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?3.35%Low
Short Interest?241.2K
Days to Cover?1.9
Free Float7.2M
Avg Daily Volume128.3K
Settlement Date2026-10-30
Financial Health
Current Ratio?0.34Weak
Quick Ratio?0.34Weak
Cash Ratio?0.19Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
S&P
97
-3.39CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.1CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
2,174.0%STRONG▾
ROA?
S&P
3
-454.1%WEAK▾
Cash Flow & Enterprise
FCF?$-16003000
Enterprise Value?$5.3M
Fundamentals ratios updated end of day